How is Mazdutide administered?
This describes how Mazdutide is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, on a once weekly schedule, generally over open-ended, titrate over months. Specific dosing is individual and beyond general information, and human evidence for Mazdutide is limited.
Administration at a glance (reference data)
- Route: Subcutaneous
- Schedule: Once weekly
- Cycle length: Open-ended, titrate over months
- Half-life: ~8 days (dose-dependent)
References
- Mazdutide in Chinese adults with obesity (Phase 3) — Ji L et al., Nat Med, 2025
- Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight (GLORY-1) — Ji et al., N Engl J Med, 2025
- A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity — Ji et al., Nature Communications, 2023
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Mazdutide
Last updated 2026-06-15.